News|Videos|December 30, 2025

Addressing the Three Pillars of PPE in Caring for Patients with High-Consequence Infectious Disease

Jill Morgan, RN, BSN, reviews this significant part of clinical care and how personal protective equipment (PPE) is essential to protecting healthcare workers.

We are continuing our series, Media Day, where we spotlight individual medical institutions and their infectious disease (ID) programs. This episode profiles Emory Healthcare.

Jill Morgan, RN, BSN, site manager, Serious Communicable Diseases Unit (SCDU), Emory University Hospital, says initially she was humbled by how little she knew about personal protective equipment when caring for patients with high-consequence infectious diseases (HCID).

“I realized that I hadn't paid any attention to that. I didn't know that there were different levels of masks or that there were different levels of gowns. I just in all my years of being a nurse, and there had been quite a few of them by then, it was just something that had escaped my notice. And I realized I'm not alone in that,” Morgan said. “An awful lot of people, both nurses, techs and physicians, really don't get much education about PPE, and so I think we need to do a better job, starting at the beginning, starting in nursing school and medical school, and really talking about what qualities are important, and what you should look for, and what that garment or article device can and can't do.”

In recent years, programs have come online to address caring for patients with HCID, including the proper donning (putting on) and doffing (removal) of PPE. Morgan has been involved with initiatives related to it. She is the co-lead of the PPE Working Group for National Emerging Special Pathogens Training and Education Center (NETEC).

She says there are 3 pillars of PPE when it comes to treating patients with HCID: source of supply, the processes, and training and competency.

Check back for a video short where Morgan will discuss at length the proper procedures for donning PPE in HCID environments.

For the source of supply, the focus is on the PPE itself.

“You need to know what PPE is required for these different pathogens, and figure out with your supply chain, with your buying habits, with your staff, what you need, and then a lot of PPE does have an expiration date. So you need to figure out, how are we going to maintain that supply how are we going to get the right sizes, where are we're going to keep all this,” Morgan said.

For the process it is all about donning and doffing PPE properly according to Morgan, and that leads into the third pillar of training and competency to teach all components of PPE.

“We have people that have been trying to teach this personal protective equipment ensemble and realize that they have many staff members who can't safely, for instance, reach their feet or shrug out of a coverall. Well, then that might not be either the right person or the right PPE to put in that space,” she said.

“I think a lot of folks got used to hearing the term PPE during COVID, the idea of gloves and gown and mask and maybe eye protection, but I think we still missed the importance of making sure that people were safely removing those things and not recontaminating themselves or their environment when they took things off,” Morgan said. “So how do we remove something? It's really important, and making sure people are competent in how they do that is really vital for their safety. It's not something that you can just leave off.”

In the next episode, Morgan discusses biocontainment unit safety, efficiency, and improving standards for PPE to protect frontline healthcare workers.


Related to this article

Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
FAQ: Shamonda Virus
As France confirms the first documented human Shamonda virus infection, a fatal encephalitis in a stem cell transplant recipient, this FAQ explains what the virus is, where it has spread, how the case was diagnosed, how the patient was likely infected and what clinicians should watch for.